![New drugs for anemia of lower-risk MDS [MDS Patient & Family Report] episode artwork](https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/6fb86eb9669a4d2de76fbe628d3c3231.jpg)
EPISODE · Mar 27, 2024 · 27 MIN
New drugs for anemia of lower-risk MDS [MDS Patient & Family Report]
from MDS Patient & Family Report · host MDS Foundation
MDS experts Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss new trials presented in the last meeting of the American Society of Hematology (ASH) 2023. They focus on luspatercept, imetelstat and roxodustat.
Embed this episode
NOW PLAYING
New drugs for anemia of lower-risk MDS [MDS Patient & Family Report]
0:00
27:18
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of MDS Patient & Family Report?
This episode is 27 minutes long.
When was this MDS Patient & Family Report episode published?
This episode was published on March 27, 2024.
Is there a transcript available for this episode?
Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.
Can I download this MDS Patient & Family Report episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!